comparemela.com
Home
Live Updates
Edison Oncologys Orotecan®: A Brighter Future For The Treatment of Recurrent Pediatric Cancers : comparemela.com
Edison Oncology's Orotecan®: A Brighter Future For The Treatment of Recurrent Pediatric Cancers
The medication, Orotecan®, is a novel oral formulation of irinotecan, an intravenous drug that has demonstrated efficacy in treating various pediatric and adult cancers.
Related Keywords
Cincinnati
,
Ohio
,
United States
,
Washington
,
Jeffrey Bacha
,
Children National Hospital
,
Duke Children Hospital Health Center
,
Edison Oncology
,
Duke Children
,
Health Center
,
Cincinnati Children
,
National Hospital
,
comparemela.com © 2020. All Rights Reserved.